Proteoglycans in mineralized (0.5 M-EDTA/4 M-guanidinium chloride-extractable) and non-mineralized (4 M-guanidinium chloride-extractable) matrices synthesized by a mouse osteoblastic-cell line MC3T3-El were characterized at different phases of mineralization in vitro. Cell cultures were labelled with [35S]sulphate and either [3H]glucosamine or 3H-labelled amino acids. At the mineralization phase a large majority of proteoglycans were extracted with 4 M-guanidinium chloride (G extract), and at least five species of labelled proteoglycans were identified; dermatan sulphate proteoglycans (DSPG, apparent Mr approx. 120000 and 70000), heparan sulphate proteoglycans (HSPG, apparent Mr approx. 200000 and 120000) and DS chains with very little core protein. DSPGs weakly bound to an octyl-Sepharose CL-4B column and HSPGs bound more tightly, whereas DS chains did not bind to the column. Amounts of labelled proteoglycans extracted with 0.5 M-EDTA/4 M-guanidinium chloride (EDTA extract) were much less than those in the G extract. Although the predominant species in the EDTA extract were comparable with the DS or DSPGs in the G extract, none of them bound to octyl-Sepharose CL-4B, indicating their lack of hydrophobicity. At the nonmineralizing phase a large chondroitin sulphate proteoglycan (Mr greater than 600000) was found in the matrix in addition to the five proteoglycan species similar to those at the mineralization phase. Although DS chains at the early phase were similar in size to those at the mineralization phase, the ratio of 2-acetamido-2-deoxy-3-0-(/8-D-gluco-4-enepyranosyluronic acid)-4-0-sulpho-D-galactose to 2-acetamido-2-deoxy-3-O-(f8-D-gluculo-4-enepyranosyluronic acid)-6-0-sulpho-D-galactose was less than that at the mineralization phase. These results agree with those of previous studies performed in vivo and suggest that alteration in the synthesis of proteoglycans is involved in the mineralization process. They also suggest that at the osteoblastic mineralization front proteoglycans undergo partial degradation and lose their hydrophobicity.
INTRODUCTION
Chondroitin sulphate proteoglycans (CSPGs) in mineralized bone tissue of human, bovine and other species have been isolated and characterized [1, 2] . These reports showed that bone proteoglycans differ from the major proteoglycan in cartilage in terms of molecular size, antigenicity and interaction with hyaluronic acid. In addition, Fisher et al. [3, 4] have demonstrated that bone proteoglycans are composed oftwo distinct small CSPGs. Their functional roles have not yet been fully clarified, although proteoglycans are generally thought to be important ground materials in bone.
It has been shown that the amount of sulphated glycosaminoglycans apparently decreases as endochondral ossification proceeds [5] . Inhibition of hydroxyapatite formation and growth in vitro by either proteoglycans or CS has been demonstrated [6] , resuiting in the widely held belief that these anionic sulphate-containing macromolecules inhibit mineralization. There has been, however, no direct evidence that proteoglycans inhibit bone mineralization in vitro as well as in vivo. Metabolism of bone proteoglycans has also not been elucidated yet, although Prince et al. [7] have demonstrated by a radiolabelling study performed in vivo that a part of newly synthesized CSPGs and/or their degradation products are deposited in the mineralizing matrix of rat calvaria. In order to approach these problems, it is important to use a simple system in vitro that resembles the bone mineralization process in vivo.
An osteoblastic-cell line, MC3T3-El, derived from newborn-mouse calvaria, developed by Kodama et al. [8] , has many osteoblastic characteristics such as high alkaline phosphatase activity [8] , synthesis of type I collagen [9] and response to parathyroid hormone [10] or 1,25-dihydroxyvitamin D3 [11] through their specific receptors. In addition, this cell line is able to mineralize in vitro under normal growth conditions [12] . This process has been considered to resemble matrix vesicle-mediated intramembranous ossification in vivo [12] . Although the proteoglycans synthesized by osteoblasts in culture have been characterized [13] [14] [15] , analyses of proteoglycans at different phases of the mineralization process have hith- erto not been performed.
In the present study, proteoglycans in the non-mineralized matrix and in the mineralized matrix synthesized by MC3T3-E1 cells were separately isolated from consecutive extracts with 4M-guanidinium chloride and 0.5 M-EDTA/4 M-guanidinium chloride as described previously [1, 16] and characterized at different phases of mineralization.
MATERIALS AND METHODS Materials
Purest-grade guanidinium chloride and urea were obtained from Wako Pure Chemicals, Osaka, Japan; Ba(NO2)2 was from Nakarai Chemicals, Kyoto, Japan; Pronase E was from Kaken Seiyaku, Tokyo, Japan; Sephadex G-50 (fine grade), DEAE-Sephacel, octylSepharose CL-4B, Sepharose CL-2B, Sepharose CL-4B and Sepharose CL-6B were from Pharmacia Fine Chemicals; cellulose-coated t.l.c. plastic sheets (without fluorescent indicator) were from Merck; aqueous solutions of Na235SO4, D- [1,6- 
Extraction of proteoglycans
After the labelling, incubation media were collected and made 4 M with respect to guanidinium chloride by the addition of solid guanidinium chloride. Matrix/cell layers were washed twice with 6 ml of ice-cold phosphatebuffered saline (0.14 M-NaCl/8 mM-sodium phosphate buffer, pH 7.4) and then subjected to extraction with 6 ml of 4 M-guanidinium chloride containing 0.1 M-6-aminohexanoic acid, 50 mM-disodium EDTA, 50 mmsodium acetate and 0.500 (w/v) Triton X-100, pH 6.0 (4 M-guanidinium chloride buffer) at 4°C for 24 h with continuous stirring [19] . The extracts were then centrifuged at 30000 g for 30 min at 4 'C. The precipitates were re-extracted in the same solution. After centrifugation, the combined supernatants were designated as 4 M-guanidinium chloride extract (G extract). Subsequently, proteoglycans in the residues were further extracted at 4 'C for 72 h with 4 M-guanidinium chloride buffer containing 0.5 M-tetrasodium EDTA, pH 7.4 [16] . Residues were spun down at 12500 g for 40 min at 4 'C. The supernatants contained material that was 0.5 M-EDTA-extractable but resistant to extraction with 4 Mguanidinium chloride alone (EDTA extract). When cultures were labelled with 45CaCl2 as described above, the EDTA extract contained approx. 20-fold the radioactivity of the G extract calculated on the basis of protein content. Benzamidine hydrochloride and N-ethylmaleimide were added to each sample before extraction to give final concentrations of 5 mm and 10 mM respectively.
Isolation of proteoglycans Proteoglycans were isolated from each extract by the procedures described previously [20] with some modifications. In brief, unincorporated radioactive precursors were removed from each extract by chromatography on Sephadex G-50 (8 ml bed volume for each 2 ml of sample) eluted with a buffer containing 7 M-urea, 0.15 M-NaCl, 50 mM-sodium acetate and 0.5 % (w/v) Triton X-100, pH 6.0 (7 M-urea buffer). Each excluded fraction (3.5 ml) was applied to DEAE-Sephacel (bed volume 2 ml) equilibrated with the 7 M-urea buffer, and then eluted with a linear NaCl gradient from 0.15 M to 1.0 M in the same solvent. Peaks of labelled proteoglycans were pooled separately, and the solvent was changed to 4 M-guanidinium chloride buffer without Triton X-100. Each pooled sample was applied to octyl-Sepharose CL-4B (bed volume 2 ml) equilibrated with 4M-guanidinium chloride buffer without Triton X-100. After being washed with 10 ml of the same solution, the column was eluted with a continuous gradient of Triton X-100 from 0 to 0.5 % [21] . The total elution volume was 50 ml at a flow rate of 3.0ml/h. Peaks of radioactivity were pooled separately. Samples were desalted and stored at -20°C until further analysis.
Gel-filtration column chromatography
Sepharose CL-2B, CL-4B and CL-6B columns (0.7 cm x 100 cm) were prepared in and eluted with 4 Mguanidinium chloride buffer containing 0.5 % Triton X-100. For each column, effluent fractions of approx. 0.9 ml were collected. Columns were calibrated with hyaluronic acid for the void volume and glucuronic acid for the total volume.
RESULTS

Distribution of labelled macromolecules
Virtually all labelled macromolecules ([35S]sulphate and [3H]glucosamine as precursors) associated with matrix/cell layers were extracted in the G extract at phase 1. At phase 2 the G extract also contained most of labelled macromolecules, and EDTA extract had only about 1 % of the 35S radioactivity of the G extract. Macromolecules labelled with [3H]glucosamine, [3H]serine or [3H]leucine were relatively rich in the EDTA extract (approx. 5-10 % of the radioactivity of G extract), suggesting that the EDTA extract was scarce in proteoglycans compared with the G extract.
Incubation media contained approximately two-thirds and one-half of labelled macromolecules in G extracts at phase 1 and phase 2 respectively. Isolation of proteoglycans by DEAE-Sephacel chromatography
Representative DEAE-Sephacel chromatographies of the G extract and the EDTA extract at phase 2 are shown Chemical analyses and enzymic digestions Alkaline borohydride treatment was done in 50 mMNaOH/ 1 M-NaBH4 at 45°C for 24 h [22] . The reaction was stopped by neutralization of the solution with acetic acid.
The HNO2 treatment was done at pH 1.5 by the method of Shively & Conrad [23] .
Hexuronic acid concentrations were determined by the method described by Bitter & Muir [24] .
Samples dissolved in 0.1 M-Tris/HCl/0.1 M-sodium acetate buffer, pH 7.3, were digested for 2 h at 37°C with chondroitinase ABC (0.1 unit for each sample) [25] or chondroitinase AC (0.2 unit for each sample) [26] . Chondro-4-sulphatase or chondro-6-sulphatase digestion was done in 50 mM-Tris/HCl/50 mM-sodium acetate buffer, pH 7.3 [25] . Disaccharides derived from chondroitinase ABC digestion were analysed by cellulose t.l.c. [27] . SDS/PAGE Isolated proteoglycans that were radiolabelled with both [35S]sulphate and [3H]leucine were dissolved in a small volume ofO.1 M-Tris/HCl buffer, pH 7.3, containing 5 mM-calcium acetate with 10 mM-EDTA, 10 mM-Nethylmaleimide, 0.36 mM-pepstatin and I mM-phenylmethanesulphonyl fluoride as proteinase inhibitors. Each sample was digested with 0.1 unit of chondroitinase ABC at 37 IC for 40 min. An equal volume of gel sample buffer as described below was added, followed by boiling of the mixture for 10 min [13] . Gel Vol. 266 fractions isolated by DEAE-Sephacel chromatography Proteoglycan fractions indicated in Fig. 1 were chromatographed on octyl-Sepharose CL-4B and were eluted with a gradient of 0-0.5 % Triton X-100 (------). The start of the gradient is indicated by an asterisk (*). Elution profiles of G extract at phase I (a), G extract at phase 2 (b) and EDTA extract (c) are shown. Each peak was pooled as indicated by the bar for further analyses.
in Fig. 1 . The G extract yielded three major peaks of 3H radioactivity (Fig. la) . Most glycoproteins labelled with
[3H]glucosamine did not bind to the column in 0.15 MNaCI. The second 3H radioactivity peak was eluted at 0.25 M-NaCl. At least two-thirds of 3H-labelled macromolecules in this fraction were excluded on Sepharose CL-2B chromatography, free from 35S radioactivity and susceptible to chondroitinase ABC digestion (results not shown). These results indicated that most of the 3H radioactivity in the second peak is in hyaluronic acid. The third 3H radioactivity peak was co-eluted with the 35S radioactivity and contained proteoglycans. This peak was collected as indicated by a bar in Fig. 1(a) for further analyses. The proportion of 3H radioactivity recovered in the proteoglycan peak was 5 % in the EDTA extract, and that in the G extract was about 21 %. The profile for G extract of phase I matrix, which contained no mineralized plaque, was very similar to that for phase 2 (results not shown). Separation of proteoglycans by hydrophobic-interaction chromatography Octyl-Sepharose CL-4B chromatographic analysis of proteoglycan fractions in G extract isolated by DEAESephacel chromatography generated three peaks of 35S radioactivity. Representative elution profiles at both phases 1 and 2 are shown in Fig. 2 . Unbound fractions (G-I) at phase 1 and phase 2 contained respectively 49 % and 43 % of the total 35S radioactivity. Second peaks (G-II) were eluted at between 0.02 % and 0.12 % Triton X-100, which comprised 34 % and 46% of the total 35S radioactivity at phase 1 and at phase 2 respectively. Third peaks (G-III) were eluted at about 0.2 % Triton X-100, which comprised 17 % at phase 1 Characterization of proteoglycans and glycosaminoglycans Each peak of 35S radioactivity isolated from octylSepharose chromatography at phase 2 was analysed by Sepharose CL-4B chromatography (Figs. 3a-3d ). Unbound fractions (G-I) were eluted at KaV = 0.56 as a symmetrical peak (Fig. 3a) . Fraction G-II was eluted at Kav = 0.43 and had a small ascending shoulder (Fig. 3b) .
Analysis of fraction G-III material after chondroitinase ABC digestion showed that approx. 70 % of the radioactive material resisted the enzymic digestion and was eluted at Kav = 0.46 (Fig. 3c) . This chondroitinase ABCresistant material was degraded by HNO2 treatment (results not shown), indicating the presence of heparan sulphate. Fraction EDTA-I (Kav = 0.52) was eluted slightly faster than fraction G-I, and the elution profile was broad (Fig. 3d) (Fig. 3f) . The G-II-large component contained approx. 30 % of the total 35S radioactivity in fraction G-II. This peak was rechromatographed on Sepharose CL-2B and was eluted at Ka, = 0.47 (results not shown). The Mr of the G-II-large component was estimated to be approx. 640000, based on the calibration of a Sepharose CL-2B column by Ohno et al. [29] . The G-II-large (Fig. 4) tion G-I at phase 1 is probably a single chain as well (Fig. 5d) . The hydrodynamic size of fraction G-II at phase 2 became smaller after alkaline borohydride treatment, and the sample contained 22% of the 3H radioactivity eluted at Kav = 0.88, indicating the presence of oligosaccharides (Fig. 5b) . The large CSPG and DSPGs of fraction G-II at phase 1 contained oligosaccharides that accounted for as much as 32% and 240 of total 3H radioactivity respectively (Figs. 5e and 5f). Fraction EDTA-I was composed of a glycosaminoglycan chain of Mr 31000 whose elution position was slightly later than those of fractions G-I and G-II (Kay = 0.49 compared with 0.40-0.43), and it contained oligosaccharides (Fig. 5c ), in contrast with fraction G-I.
Fractions G-I and G-II at both phases contained small amounts of chondroitinase ABC-resistant material ( Table 1 ). The 35S radioactivity in these species was eluted at Kav = 0.50 and 0.22 respectively, which corresponded to HS chains and the HSPG in fraction G-III (results not shown). Core protein-oligosaccharide complexes of DSPGs Proteoglycans labelled with [35S]sulphate and [3H]-leucine as precursors were purified by the same procedures as described above. Samples of fractions G-I, G-II and G-III at phase 2 were subjected to chondroitinase ABC digestion, and then the digests were analysed by SDS/PAGE followed by fluorography (Fig. 6) Unbound fraction (G-I) from octyl-Sepharose CL-4B chromatography at phase 2 was subjected to chondroitinase ABC digestion, followed by t.l.c.: 0, 35S radioactivity; 0, 3H radioactivity. Spots represent migration positions of authentic ADi-2,4-bis-S, ADi-6S, ADi-2S, ADi-4S and ADi-OS. Peak 2 fractions were collected as indicated for further analysis.
the DSPG in fraction EDTA-I was not possible because of low radioactivity in this fraction.
Disaccharide composition of CSPG and DSPGs
Disaccharides of each sample were analysed by t.l.c. after chondroitinase ABC digestion. In each chromatogram four migration positions of 35S radioactivity were identified, namely a peak remaining at origin (peak 1) and three peaks that had migrated (peaks 2, 3 and 4) (Fig. 7) . Peaks 3 and 4 were identical with those of ADi-6S and ADi-4S standards respectively. Radioactivity remaining at origin was resistant to chondroitinase ABC digestion, consistent with the presence of heparan sulphate and oligosaccharides on core proteins. Further analysis of peak 2 material by using the same t.l.c. after chondro-4-sulphatase and chondro-6-sulphatase digestion indicated that more than 80 % of this material is ADi-4,6-bis-S (results not shown). The disaccharide composition of each glycosaminoglycan chain is summarized in Table 2 . Small amounts of over-sulphated disaccharides were detected in each sample. Although the predominant disaccharide was ADi-4S in each case, the ratio of ADi-4S to ADi-6S varied among samples; it was significantly higher in the phase 2 
DISCUSSION
In the present study proteoglycans synthesized by an osteoblastic-cell line MC3T3-E1 were characterized at different phases of culture period with or without mineralization. Proteoglycans associated with matrix/cell layers were extracted with sequential dissociative solution conditions, 4 M-guanidinium chloride buffer followed by 4 M-guanidinium chloride buffer containing 0.5 M-EDTA. This extraction procedure has been shown to extract matrix proteins associated with non-mineralized matrix separately from those in mineralized matrix [1, 16] [31] . The HSPGs in the G extract were separated into two Mr species (apparent Mr 200 000 and 120000), and had glycosaminoglycan chains of Mr 30000. HSPGs showed stronger binding to octyl-Sepharose than did DSPGs, suggesting that these have hydrophobic domains that intercalate into the plasma membrane. The HSPGs, which were probably co-purified with DSPGs, in osteoblasts may be related to TGF-,81 receptors, as reported for fibroblasts [32, 33] . These results in the phase 1 study are similar to those obtained by Beresford et al. [13] and Ecarot-Charrier & Broekhuyse [14] , who used an osteoblast primary culture system without mineralization.
Very few 35S-labelled proteoglycans were present in the EDTA extract, which mainly contained DS chains and unique DSPGs without hydrophobic interaction with octyl-Sepharose. They were separated by SDS/ PAGE but not by gel-filtration chromatography, and their average molecular size was smaller than that of DSPGs in the G extract. Metabolic radiolabelling of bone proteoglycans in vivo has demonstrated three classes of proteoglycans similar to those in this study: a large CSPG excluded from Sepharose CL-6B and a small CSPG (Kav = 0.24) in non-mineralized bone matrix and a smaller CSPG (Kav = 0.36) in mineralized matrix [7] .
Similar observations were reported by Tian et al. [19] . Thus it is possible that mineralization of the MC3T3-E1 cell culture system reflects that of bone in terms of metabolism of proteoglycans as well as previous studies in morphology [12] . Although the relationship between the small CSPG/DSPGs in the non-mineralized matrix and the smaller CSPG/DSPGs in mineralized matrix is as yet uncertain, our results suggest that the hydrophobic DSPGs give rise to less hydrophic and smaller species by a partial cleavage of a hydrophobic domain.
Scott and co-workers and others have reported that proteoglycans occupy the trans-fibrillar loci of collagen fibrils in soft connective tissues such as tendon and skin (see ref. [34] for review). It has also been suggested by an electron microscopy that core proteins of proteoglycans interact with collagen fibrils [34] . Since the occupied region of collagen fibrils is suggested to be an initiation site of mineralization, proteoglycans possibly inhibit the mineralization process [34] . In contrast with soft connective tissues, proteoglycans in bone have been demonstrated to be located in the interfibrillar space and have not occupied any bands of collagen fibrils [34] . Although proteoglycans in bone (CSPGs) have different characteristics from those in skin and tendon (DSPGs), the core proteins have been shown to be very similar [35] [36] [37] . Taken together, modification of the core proteins of proteoglycans is probably important for interaction between proteoglycans and collagen fibrils. For example, partial degradation of proteoglycans by the removal of the hydrophobic domain in core proteins may lead to the dissociation of proteoglycans from the bands of collagen fibrils in bone, thus creating initiation sites for mineralization.
Synthesis of proteoglycans by MC3T3-El cells at two different culture phases with or without mineralization showed distinct features. The content of the large CSPG in the G extract at early phase was more than that at the mineralization phase. A similar observation has been reported by Reddi et al. [38] in the process of osteogenesis induced by the implantation of demineralized bone powder in rats. In endochondral ossification a decrease of large cartilagenous proteoglycans has been demonstrated to accompany the mineralization process [5] . In addition, we have observed that 1,25-dihydroxyvitamin D3, which stimulated mineralization by MC3T3-El cells in vitro (T. Matsumoto, Y. Takeuchi & E. Ogata, unpublished work), caused a decrease in the content of the large CSPG [39] . Thus it is possible that the large CSPG may have an inhibitory role in mineralization. It has been reported that a large CSPG was actively synthesized at the undifferentiated stage and was decreased through a differentiation process in some systems [40, 41] . MC3T3-El cells were proliferative after confluency at the undifferentiated early phase (phase 1), whereas the cell number did not increase at mineralization phase (phase 2) [12] . Thus the content of the large CSPG may reflect a stage of differentiation or may be involved in cell proliferation activity. Even if this were the case, it is still possible that the differences in proteoglycan synthesis contribute to mineralization because the change in proteoglycan synthesis due to loss of potency to proliferate may be one of the triggers for mineralization.
The MC3T3-E1 cell line provides a good model for studying mineralization in vitro, and further investigation on precise roles of bone proteoglycans in the mineralization process with the use of this system will be important.
